A high-throughput, whole cell assay to identify compounds active against carbapenem-resistant Klebsiella pneumoniae.
Enteric Gram-negative rods (GNR), which are frequent causes of community-acquired and nosocomial infections, are increasingly resistant to the antibiotics in our current armamentarium. One solution to this medical dilemma is the development of novel classes of antimicrobial compounds. Here we report...
Main Authors: | Julie Liao, George Xu, Emily E Mevers, Jon Clardy, Paula I Watnick |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0209389 |
Similar Items
-
Rapid Nanopore Assay for Carbapenem-Resistant Klebsiella pneumoniae
by: Haofu Niu, et al.
Published: (2019-07-01) -
Limiting and controlling carbapenem-resistant Klebsiella pneumoniae
by: Saidel-Odes L, et al.
Published: (2013-12-01) -
Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
by: Lin Di, et al.
Published: (2018-10-01) -
Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
by: Zhe Wang, et al.
Published: (2018-01-01) -
Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
by: Chen X, et al.
Published: (2020-05-01)